A novel automated SARS-CoV-2 saliva PCR test protects a global asymptomatic workforce.
Asymptomatic Diseases
/ epidemiology
COVID-19
/ diagnosis
COVID-19 Nucleic Acid Testing
/ methods
Diagnostic Tests, Routine
/ methods
Humans
Nasopharynx
/ virology
Pandemics
/ prevention & control
RNA, Viral
/ genetics
Real-Time Polymerase Chain Reaction
/ methods
SARS-CoV-2
/ genetics
Saliva
/ virology
Specimen Handling
/ methods
Workforce
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
16 06 2021
16 06 2021
Historique:
received:
05
03
2021
accepted:
03
06
2021
entrez:
17
6
2021
pubmed:
18
6
2021
medline:
8
7
2021
Statut:
epublish
Résumé
Regular PCR testing of nasopharyngeal swabs from symptomatic individuals for SARS-CoV-2 virus has become the established method by which health services are managing the COVID-19 pandemic. Businesses such as AstraZeneca have also prioritised voluntary asymptomatic testing to keep workplaces safe and maintain supply of essential medicines to patients. We describe the development of an internal automated SARS-CoV-2 testing programme including the transformative introduction of saliva as an alternative sample type.
Identifiants
pubmed: 34135391
doi: 10.1038/s41598-021-92070-w
pii: 10.1038/s41598-021-92070-w
pmc: PMC8209156
doi:
Substances chimiques
RNA, Viral
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
12676Références
Emerg Infect Dis. 2020 Nov;26(11):2770-2771
pubmed: 32917294
Lancet Infect Dis. 2020 May;20(5):565-574
pubmed: 32213337
Ann Intern Med. 2021 Apr;174(4):501-510
pubmed: 33428446
N Engl J Med. 2020 Sep 24;383(13):1283-1286
pubmed: 32857487
Int J Infect Dis. 2020 Jul;96:288-290
pubmed: 32437933
J Clin Virol. 2020 Sep;130:104567
pubmed: 32750665